-
Subject Areas on Research
-
A "shocking" new code status.
-
A Bayesian approach to subgroup identification.
-
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
-
A Global Collaborative to Advance Genomic Medicine.
-
A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer.
-
A framework for self-experimentation in personalized health.
-
A generalized estimator of the attributable benefit of an optimal treatment regime.
-
A hub for bench-to-bedside pharmacogenomic-based research.
-
A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project.
-
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
-
A note from the editors.
-
A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy.
-
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab.
-
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
-
A public resource facilitating clinical use of genomes.
-
A rationalized approach to the treatment of patients infected with hepatitis B.
-
A sociology of precision-in-practice: The affective and temporal complexities of everyday clinical care.
-
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
-
A view from the side-line.
-
APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's.
-
Academic medical centers: ripe for rapid-learning personalized health care.
-
Achieving the goals of effective, safe, and individualized cancer care.
-
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology.
-
Adjusting for misclassification in a stratified biomarker clinical trial.
-
Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium.
-
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.
-
Affiliate network members as force amplifiers of genomic medicine research.
-
Aligning incentives to fulfil the promise of personalised medicine.
-
Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.
-
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.
-
American Society of Clinical Oncology 2013 top five list in oncology.
-
An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions.
-
An informatics research agenda to support precision medicine: seven key areas.
-
An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial.
-
An outlook on precision surgery.
-
Analysis of Factors Associated With In-hospital Mortality in Lung Cancer Chemotherapy Patients With Neutropenia.
-
Androgen receptor variant-driven prostate cancer II: advances in laboratory investigations.
-
Anticoagulation Resumption After Stroke from Atrial Fibrillation.
-
Antiplatelet therapy beyond 2012: role of personalized medicine.
-
Antipsychotics and dementia: where do we go from here?
-
Assessing conscientious personality in primary care: an opportunity for prevention and health promotion.
-
Assessing feasibility of delivering pharmacogenetic testing in a community pharmacy setting.
-
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
-
At the intersection of precision medicine and population health: an implementation-effectiveness study of family health history based systematic risk assessment in primary care.
-
Author's Reply.
-
Automated next-generation profiling of genomic alterations in human cancers.
-
Auxiliary variable-enriched biomarker-stratified design.
-
Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program.
-
Battlefield to Bedside: Bringing Precision Medicine to Surgical Care.
-
Biobanking for Metabolomics and Lipidomics in Precision Medicine.
-
Biomarker science: on a theme of personalized medicine.
-
Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies.
-
Biomarkers as drug development tools: discovery, validation, qualification and use.
-
Biomarkers for equine joint injury and osteoarthritis.
-
Biospecimens and biorepositories for the community pathologist.
-
Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
-
Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.
-
Building evidence and measuring clinical outcomes for genomic medicine.
-
Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine.
-
Cancer Data Science and Computational Medicine.
-
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
-
Cardiovascular Research and the National Academy of Medicine: Advancing Progress in Science and Medicine: Part 2: What We Do.
-
Cardiovascular precision medicine: hope or hype?
-
Cell plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010.
-
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
-
Changing the Course of Cancer Care With Greater Precision.
-
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
-
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
-
Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
-
Clinical genomic testing: getting it right.
-
Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer.
-
Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
-
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
-
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine.
-
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
-
Comment on “Comparison of patient specific dose metrics between chest radiography, tomosynthesis, and CT for adult patients of wide ranging body habitus” [Med. Phys. 41(2), 023901 (12pp.) (2014)].
-
Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform.
-
Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests.
-
Comparative effectiveness research, genomics-enabled personalized medicine, and rapid learning health care: a common bond.
-
Comparison of patient specific dose metrics between chest radiography, tomosynthesis, and CT for adult patients of wide ranging body habitus.
-
Complexity of Delivering Precision Medicine: Opportunities and Challenges.
-
Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift.
-
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
-
Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
-
Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals.
-
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
-
Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
-
Creating and parameterizing patient-specific deep brain stimulation pathway-activation models using the hyperdirect pathway as an example.
-
Current Opportunities and Future Vision of Precision Medicine in Radiation Oncology.
-
Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling.
-
Designing a broad-spectrum integrative approach for cancer prevention and treatment.
-
Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.
-
Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer.
-
Development of a Comprehensive, Nonsurgical Joint Health Program for People With Osteoarthritis: A Case Report.
-
Development of a fertility risk calculator to predict individualized chance of ovarian failure after chemotherapy.
-
Development of a precision medicine pipeline to identify personalized treatments for colorectal cancer.
-
Development of predictive models for all individual questions of SRS-22R after adult spinal deformity surgery: a step toward individualized medicine.
-
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.
-
Diffuse large B-cell lymphoma.
-
Digital pathology and computational image analysis in nephropathology.
-
Digital pathology in nephrology clinical trials, research, and pathology practice.
-
Driving biology: The effect of standardized wound management on wound biomarker profiles.
-
Dynamic treatment regimes, past, present, and future: A conversation with experts.
-
EUS-FNA and needle echogenicity in the age of personalized medicine.
-
Educating future providers of personalized medicine.
-
Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial.
-
Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
-
Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Toward Personalized Management.
-
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
-
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
-
Enhancing digital tomosynthesis (DTS) for lung radiotherapy guidance using patient-specific deep learning model.
-
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.
-
Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine.
-
Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial.
-
Evidence-Based versus Personalized Medicine in Pediatric Urology: The Evidence Supports Evidence-Based Medicine.
-
Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
-
Family history assessment significantly enhances delivery of precision medicine in the genomics era.
-
Finding the right balance between precision medicine and personalized care.
-
Functional assay to guide precision radiotherapy by assessing individual patient radiosensitivity.
-
Future of Personalized Cardiovascular Medicine: JACC State-of-the-Art Review.
-
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.
-
Genetic determinants of renal transplant outcome: where do we stand?
-
Genetic lesions in diffuse large B-cell lymphomas.
-
Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.
-
Genic intolerance to functional variation and the interpretation of personal genomes.
-
Genome Engineering for Personalized Arthritis Therapeutics.
-
Genome technologies and personalized dental medicine.
-
Genomic and personalized medicine: foundations and applications.
-
Genomic stratification for the treatment of lymphomas.
-
Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
-
Genotyping Array Design and Data Quality Control in the Million Veteran Program.
-
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
-
Global approaches to genomic medicine implementation.
-
Global implementation of genomic medicine: We are not alone.
-
Global position paper on cardiovascular regenerative medicine.
-
Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.
-
Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee.
-
Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?
-
Homologous Recombination Repair Gene Variants and Outcomes Among Patients With Prostate Cancer Treated With Poly (ADP-ribose) Polymerase Inhibitors.
-
Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.
-
How Advances in Imaging Will Affect Precision Radiation Oncology.
-
Hyperthyroidism in the personalized medicine era: the rise of mathematical optimization.
-
IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies.
-
ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents.
-
Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.
-
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease.
-
Impact of Rare and Common Genetic Variants on Diabetes Diagnosis by Hemoglobin A1c in Multi-Ancestry Cohorts: The Trans-Omics for Precision Medicine Program.
-
Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience.
-
Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand.
-
Implementing genome-driven personalized cardiology in clinical practice.
-
Improving Clinical Outcomes in the Era of Information Ubiquity.
-
Improving the management of dyspnea in the community using rapid learning approaches.
-
Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.
-
Individualized Homeopathy: A Consideration of Its Relationship to Psychotherapy.
-
Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
-
Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial.
-
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.
-
Individualized therapy for persistent asthma in young children.
-
Individualizing duration of antibiotic therapy in community-acquired pneumonia.
-
Individualizing pharmacogenomic test results in the context of the microbiome.
-
Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology.
-
Inference on treatment effects for targeted clinical trials under enrichment design.
-
Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
-
Inherited causes of clonal haematopoiesis in 97,691 whole genomes.
-
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
-
Integrating Medical Genetics Into Precision Oncology Practice in the Veterans Health Administration: The Time Is Now.
-
Integration of Personalized Health Planning and Shared Medical Appointments for Patients with Type 2 Diabetes Mellitus.
-
Integrative molecular profiling of routine clinical prostate cancer specimens.
-
Interactive or static reports to guide clinical interpretation of cancer genomics.
-
Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association.
-
Introducing personalized health for the family: the experience of a single hospital system.
-
In vitro generation of renal tubular epithelial cells from fibroblasts: implications for precision and regenerative medicine in nephrology.
-
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
-
Logistical Challenges Associated With Implementing Precision Medicine-Reply.
-
Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?
-
Making Clinical Practice Guidelines Pragmatic: How Big Data and Real World Evidence Can Close the Gap.
-
Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable.
-
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research.
-
Management of glioblastoma: State of the art and future directions.
-
Managing Increased Accessibility to Pharmacogenomic Data.
-
Medical genomics: Gather and use genetic data in health care.
-
Medical oncologists' perspectives of the Veterans Affairs National Precision Oncology Program.
-
Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
-
Metabolomics reveals intratumor heterogeneity - Implications for precision medicine.
-
Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.
-
Methionine metabolism in health and cancer: a nexus of diet and precision medicine.
-
Mind-mapping for lung cancer: towards a personalized therapeutics approach.
-
Missed diagnoses: Clinically relevant lessons learned through medical mysteries solved by the Undiagnosed Diseases Network.
-
Missing in Action: African Ancestry Brain Research.
-
Mobile health technology for personalized primary care medicine.
-
Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project.
-
Molecular Imaging and Precision Medicine in Head and Neck Cancer.
-
Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
-
Molecular classification of endometrial cancer: entering an era of precision medicine.
-
Molecular markers for incidence, prognosis, and response to therapy.
-
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.
-
Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.
-
Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.
-
Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges.
-
New Approaches to SCLC Therapy: From the Laboratory to the Clinic.
-
Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?
-
North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative.
-
Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting.
-
Novel therapies for epilepsy in the pipeline.
-
Nuclear Medicine and Molecular Imaging-An Impactful Decade of Contributions to Patient Care and Driving Precision Medicine.
-
ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
-
On Enrichment Strategies for Biomarker Stratified Clinical Trials.
-
Only connect: personal genomics and the future of American medicine.
-
Open Humans: A platform for participant-centered research and personal data exploration.
-
Opportunities for the Cardiovascular Community in the Precision Medicine Initiative.
-
Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.
-
Opportunities, resources, and techniques for implementing genomics in clinical care.
-
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.
-
Osteoarthritis--a case for personalized health care?
-
Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
-
Overcoming barriers in the implementation of personalized medicine into clinical practice.
-
PET-Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors.
-
PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.
-
PET/Computed Tomography and Precision Medicine: Gastric Cancer.
-
PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
-
Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial.
-
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
-
Patient perspectives and involvement in precision medicine research.
-
Patient-Centered Communication for Discussing Oncotype DX Testing.
-
Patient-derived micro-organospheres enable clinical precision oncology.
-
Patient-specific quantification of image quality: An automated method for measuring spatial resolution in clinical CT images.
-
Patient-specific radiation dose and cancer risk estimation in CT: part I. development and validation of a Monte Carlo program.
-
Patient-specific radiation dose and cancer risk estimation in CT: part II. Application to patients.
-
Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine.
-
Perioperative fluid and hemodynamic management within an enhanced recovery pathway.
-
Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities.
-
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation.
-
Personalized analgesic management for cesarean delivery.
-
Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.
-
Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
-
Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
-
Personalized health care in 2013: a status report on the impact of genomics.
-
Personalized health care: from theory to practice.
-
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.
-
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.
-
Personalized medicine and human genetic diversity.
-
Personalized medicine in women's obesity prevention and treatment: implications for research, policy and practice.
-
Personalized medicine: progress and promise.
-
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
-
Personalized targeted therapy for esophageal squamous cell carcinoma.
-
Personalized treatment in patients with colorectal liver metastases.
-
Personalized treatment of lung cancer.
-
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
-
Pharmacogenetic guidance for antiplatelet treatment.
-
Pharmacogenomics courses in pharmacy school curricula.
-
Pharmacogenomics for personalized pain medicine.
-
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
-
Pharmacogenomics in pediatric rheumatology.
-
Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
-
PhenX RISING: real world implementation and sharing of PhenX measures.
-
PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases.
-
Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.
-
Physiologic goal-directed therapy in the perioperative period: the volume prescription for high-risk patients.
-
Platelet monitoring for PCI: is it really necessary?
-
Platelet-Mediated Thrombosis: From Bench to Bedside.
-
Population genomics in South East Asia captures unexpectedly high carrier frequency for treatable inherited disorders.
-
Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.
-
Potential predictive biomarkers for individualizing treatment for men with castration-resistant prostate cancer.
-
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
-
Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR+/HER2- Breast Cancer.
-
Practical ethics: establishing a pathway to benefit for complex pharmacogenomic tests.
-
Precision Medicine Approaches When Prostate Cancer Akts Up.
-
Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
-
Precision Medicine and PET/Computed Tomography in Melanoma.
-
Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
-
Precision Medicine and PET/Computed Tomography: Time Has Arrived.
-
Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
-
Precision Medicine for Critical Illness and Injury.
-
Precision Medicine for Heart Failure: Lessons From Oncology.
-
Precision Medicine: From Science To Value.
-
Precision Medicine: Towards Individualized Dosing in Pediatric Rheumatology.
-
Precision and predictive medicine: lessons learned from our oncology colleagues.
-
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
-
Precision diagnosis: a view of the clinical decision support systems (CDSS) landscape through the lens of critical care.
-
Precision health: Advancing symptom and self-management science.
-
Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease.
-
Precision medicine gets an ASSIST in diagnostic testing.
-
Precision medicine in addiction research: where has the time gone?
-
Precision oncology: A primer for pediatric surgeons from the APSA cancer committee.
-
Precision treatment for metastatic non-small cell lung cancer: A conceptual overview.
-
Predicting critical illness mortality and personalizing therapy: moving to multi-dimensional data.
-
Predicting risk of diabetic retinopathy from retinal vessel analysis: personalized medicine in transition.
-
Predictors of consent to pharmacogenomics testing in the IDEAL study.
-
Preserving an integrated view of informatics.
-
Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
-
Prostate-specific membrane antigen-targeted theranostics: past, present, and future approaches.
-
Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
-
Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.
-
Radiogenomics: what it is and why it is important.
-
Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis.
-
Rationale and design of the Kidney Precision Medicine Project.
-
Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies.
-
Realizing the Full Potential of Precision Medicine in Health and Health Care.
-
Realizing the opportunities of genomics in health care.
-
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study.
-
Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs.
-
Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care.
-
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
-
Resilience in Clinical Care: Getting a Grip on the Recovery Potential of Older Adults.
-
Resistance to antiplatelet drugs: what progress has been made?
-
Response to: 'Lack of standardization of ANA and implications for drug development and precision medicine' by Mahler.
-
Review of the biology of bleeding and clotting in the surgical patient.
-
Role of Imaging in the Era of Precision Medicine.
-
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitors.
-
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
-
Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).
-
Sex and gender: modifiers of health, disease, and medicine.
-
Sleep Pharmacogenetics: The Promise of Precision Medicine.
-
Start me up: ways to encourage sharing of genomic information with research participants.
-
Statistical issues and advances in cancer precision medicine research.
-
Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine.
-
Survey of US public attitudes toward pharmacogenetic testing.
-
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
-
Symptom-based patient stratification in mental illness using clinical notes.
-
Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine?
-
Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?
-
Tailoring nutrition therapy to illness and recovery.
-
Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
-
Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancer.
-
Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
-
Targeting treatments for depression: what can our patients tell us?
-
The Adolescent and Young Adult with Cancer: A Developmental Life Course Perspective.
-
The Call for Precision Health Trials in Older Adults: One Size Does Not Fit All.
-
The Current and Evolving Role of PET in Personalized Management of Lung Cancer.
-
The Genomic Medicine Integrative Research Framework: A Conceptual Framework for Conducting Genomic Medicine Research.
-
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution.
-
The IGNITE network: a model for genomic medicine implementation and research.
-
The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design.
-
The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis.
-
The National Academies' Roundtable on Genomics and Precision Health: Where we have been and where we are heading.
-
The Uniformed Services University's Surgical Critical Care Initiative (SC2i): Bringing Precision Medicine to the Critically Ill.
-
The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.
-
The current clinical value of the DCIS Score.
-
The enduring importance of family health history in the era of genomic medicine and risk assessment.
-
The human pain genetics database: an interview with Luda Diatchenko.
-
The imperative of overcoming barriers to the conduct of large, simple trials.
-
The influence of CYP2C19 polymorphisms on the pharmacokinetics, pharmacodynamics, and clinical effectiveness of P2Y(12) inhibitors.
-
The next 10 years in personalized medicine in cardiology.
-
The oral microbiome in health and disease and the potential impact on personalized dental medicine.
-
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
-
The rise of genomic profiling in ovarian cancer.
-
The worry about clopidogrel "nonresponsiveness": identification and treatment in the post-percutaneous coronary intervention patient.
-
Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer.
-
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
-
To Splice or Not to Splice, That Is the Treatment.
-
Toward a Shared Vision for Cancer Genomic Data.
-
Toward precision prescribing for methadone: Determinants of methadone deposition.
-
Towards a personalised approach for obesity treatment: one size does not fit all.
-
Towards precision medicine: Accurate predictive modeling of infectious complications in combat casualties.
-
Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.
-
Toxin-based targeted therapy for malignant brain tumors.
-
Translational Bioinformatics: Past, Present, and Future.
-
Treatment of steroid-resistant nephrotic syndrome in the genomic era.
-
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
-
Twenty-First Century Cures Act.
-
Understanding the biological basis of psychiatric disease: What's next?
-
Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
-
Update: Acute coronary syndromes (V). Personalized antiplatelet therapy.
-
Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.
-
Using decision lists to construct interpretable and parsimonious treatment regimes.
-
Using evidence-based algorithms to improve clinical decision making: the case of a first-time anterior shoulder dislocation.
-
Using mathematical models to understand metabolism, genes, and disease.
-
Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy.
-
Utilizing Precision Medicine to Estimate Timing for Surgical Closure of Traumatic Extremity Wounds.
-
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
-
Validation of a host response test to distinguish bacterial and viral respiratory infection.
-
Value of Personalized Medicine.
-
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
-
Ways of knowing in precision health.
-
What will it take to implement genomics in practice? Lessons from the IGNITE Network.
-
What's New in Genetic Testing for Cancer Susceptibility?
-
Which infants should receive indomethacin prophylaxis: moving closer to individualized medicine in the neonatal intensive care unit.
-
Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial.
-
Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program.
-
Will Precision Medicine Move Us beyond Race?
-
hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine.
-
Keywords of People
-
Bitting, Rhonda L,
Associate Professor of Medicine,
Medicine, Medical Oncology
-
Granger, Christopher Bull,
Professor of Medicine,
School of Nursing
-
Halabi, Susan,
Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Orlando, Lori Ann,
Professor of Medicine,
Medicine, General Internal Medicine
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Shaw, Ryan,
Associate Professor in the School of Nursing,
Duke Innovation & Entrepreneurship
-
Tenenbaum, Jessica Dale,
Assistant Professor of Biostatistics & Bioinformatics,
Duke Science & Society